{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:26:55Z","timestamp":1792844815369,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05818-0","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T23:04:30Z","timestamp":1624575870000},"page":"3853-3858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Refractory fibromyalgia"],"prefix":"10.1007","volume":"40","author":[{"given":"Luis F.","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-5260","authenticated-orcid":false,"given":"Maritza","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasec","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"issue":"1","key":"5818_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31887\/DCNS.2018.20.1\/whauser","volume":"20","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user W, Fitzcharles MA (2018) Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci 20(1):53","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"5818_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/ijcp.12757","volume":"70","author":"LM Arnold","year":"2016","unstructured":"Arnold LM, Gebke KB, Choy EHS (2016) Fibromyalgia: management strategies for primary care providers. Int J Clin Pract 70(2):99\u2013112","journal-title":"Int J Clin Pract"},{"key":"5818_CR3","doi-asserted-by":"publisher","first-page":"s467","DOI":"10.1016\/j.rbr.2017.05.006","volume":"57","author":"RE Heymann","year":"2017","unstructured":"Heymann RE, Paiva ES, Martinez JE et al (2017) New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol 57:s467-476","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"5818_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.berh.2015.04.018","volume":"29","author":"JN Ablin","year":"2015","unstructured":"Ablin JN, Buskila D (2015) Update on the genetics of the fibromyalgia syndrome. Best Pract Res Clin Rheumatol 29(1):20\u201328","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"5818_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrrheum.2016.149","volume":"12","author":"R Bennett","year":"2016","unstructured":"Bennett R (2016) Shining a light on fibromyalgia treatment. Nat Rev Rheumatol 12(10):568\u2013569","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5818_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","volume":"7","author":"AG Copay","year":"2007","unstructured":"Copay AG, Subach R, Glassman SD et al (2007) Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7(5):541\u2013546","journal-title":"Spine J"},{"key":"5818_CR7","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3899\/jrheum.090368","volume":"36","author":"EH Choy","year":"2009","unstructured":"Choy EH, Arnold LM, Clauw DJ et al (2009) Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 36:2330\u20132334","journal-title":"J Rheumatol"},{"issue":"2","key":"5818_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D et al (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102\u2013109","journal-title":"J Clin Epidemiol"},{"key":"5818_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3899\/jrheum.081090","volume":"36","author":"RM Bennet","year":"2009","unstructured":"Bennet RM, Bushmakin AG, Cappelleri JC et al (2009) Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 36:1304\u20131311","journal-title":"J Rheumatol"},{"key":"5818_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pain.2010.02.043","volume":"149","author":"ME Geisser","year":"2010","unstructured":"Geisser ME, Clauw DJ, Strand V et al (2010) Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain 149:373\u2013378","journal-title":"Pain"},{"key":"5818_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1526-4637.2010.01047.x","volume":"12","author":"LM Arnold","year":"2011","unstructured":"Arnold LM, Zlateva G, Sadosky A et al (2011) Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin. Pain Med 12:260\u2013267","journal-title":"Pain Med"},{"key":"5818_CR12","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3899\/jrheum.090139","volume":"36","author":"JI Hudson","year":"2009","unstructured":"Hudson JI, Arnold LM, Bradley LA et al (2009) What makes fibromyalgia patients feel better? Correlations between patient global impression of improvement and changes in clinical symptoms and function: a pooled analysis of four, randomized, placebo-controlled trials of duloxetine. J Rheumatol 36:2517\u20132522","journal-title":"J Rheumatol"},{"issue":"3","key":"5818_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.33360","volume":"64","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Williams DA, Hudson JI et al (2012) Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum 64(3):885\u2013894","journal-title":"Arthritis Rheum"},{"key":"5818_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","volume":"72","author":"E Nuesch","year":"2013","unstructured":"Nuesch E, H\u00e4user W, Bernardy K et al (2013) Comparative efficacy of pharmacological and nonpharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 72:955\u2013962","journal-title":"Ann Rheum Dis"},{"key":"5818_CR15","unstructured":"Holman A (1998) Effect of lorazepam on pain score for refractory fibromyalgia. Arthritis Rheum 41(9)"},{"issue":"3","key":"5818_CR16","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.jpain.2005.01.116","volume":"6","author":"R Dworkin","year":"2005","unstructured":"Dworkin R, Sharma U, Stacey B et al (2005) Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients. J Pain 6(3):S30","journal-title":"J Pain"},{"key":"5818_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1874312901004010035","volume":"4","author":"BR Stacey","year":"2010","unstructured":"Stacey BR, Emir B, Petersel D et al (2010) Pregabalin in treatment-refractory fibromyalgia. Open Rheumatol J 4:35","journal-title":"Open Rheumatol J"},{"issue":"3","key":"5818_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1155\/2013\/918216","volume":"18","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, Ste-Marie PA, Goldenberg DL et al (2013) Canadian guidelines for the diagnosis and management of Fibromyalgia syndrome: executive summary. Pain Res Manag 18(3):119\u2013126","journal-title":"Pain Res Manag"},{"key":"5818_CR19","doi-asserted-by":"crossref","unstructured":"Fitzcharles MA, Shir Y, Ablin JN el at (2013) Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines. Evid Based Complement Alternat Med 2013:485272","DOI":"10.1155\/2013\/528952"},{"issue":"12","key":"5818_CR20","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00296-017-3792-4","volume":"37","author":"F Salaffi","year":"2017","unstructured":"Salaffi F, Gerardi MC, Atzeni F et al (2017) The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int 37(12):2035\u20132042","journal-title":"Rheumatol Int"},{"issue":"9","key":"5818_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ejp.1252","volume":"22","author":"MA Fitzcharles","year":"2018","unstructured":"Fitzcharles MA, Perrot S, H\u00e4user W (2018) Comorbid fibromyalgia: a qualitative review of prevalence and importance. Eur J Pain 22(9):1565\u20131576","journal-title":"Eur J Pain"},{"key":"5818_CR22","doi-asserted-by":"crossref","unstructured":"H\u00e4user W, Perrot S, Sommer C et al (2017) Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep 2(3)","DOI":"10.1097\/PR9.0000000000000598"},{"key":"5818_CR23","doi-asserted-by":"publisher","first-page":"1759720X2096612","DOI":"10.1177\/1759720X20966123","volume":"12","author":"C L\u00f3pez-Medina","year":"2020","unstructured":"L\u00f3pez-Medina C, Molt\u00f3 A (2020) Comorbid pain in axial spondyloarthritis, including fibromyalgia. Ther Adv Musculoskelet Dis 12:1759720X20966123","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"5818_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.pain.2010.04.003","volume":"149","author":"L Arendt-Nielsen","year":"2010","unstructured":"Arendt-Nielsen L, Nie H, Laursen MB et al (2010) Sensitization in patients with painful knee osteoarthritis. Pain 149(3):573\u2013581","journal-title":"Pain"},{"key":"5818_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.joca.2015.02.163","volume":"23","author":"C Fingleton","year":"2015","unstructured":"Fingleton C, Smart K, Moloney N et al (2015) Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil 23:1043\u20131056","journal-title":"Osteoarthr Cartil"},{"issue":"12","key":"5818_CR26","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s10067-007-0636-8","volume":"26","author":"L Bazzichi","year":"2007","unstructured":"Bazzichi L, Rossi A, Giuliano T et al (2007) Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 26(12):2115\u20132120","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5818_CR27","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s10067-017-3556-2","volume":"36","author":"S Haliloglu","year":"2017","unstructured":"Haliloglu S, Ekinci B, Uzkeser H et al (2017) Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity. Clin Rheumatol 36(7):1617\u20131621","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5818_CR28","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s10067-019-04498-1","volume":"38","author":"CE Tagoe","year":"2019","unstructured":"Tagoe CE, Sheth T, Golub E et al (2019) Rheumatic associations of autoimmune thyroid disease: a systematic review. Clin Rheumatol 38(7):1801\u20131809","journal-title":"Clin Rheumatol"},{"key":"5818_CR29","doi-asserted-by":"publisher","unstructured":"Vidal M, Lane NE (2020) The importance of vitamin D. Rheumatol Orthop Med 5. https:\/\/doi.org\/10.15761\/ROM.1000171","DOI":"10.15761\/ROM.1000171"},{"issue":"3","key":"5818_CR30","first-page":"105","volume":"14","author":"LF Vidal","year":"2019","unstructured":"Vidal LF, Morales R, Cueva C et al (2019) Serum levels of vitamin D in women treated at rheumatology services in Lima. Int J Clin Rheumatol 14(3):105\u2013112","journal-title":"Int J Clin Rheumatol"},{"issue":"2","key":"5818_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jpain.2017.08.009","volume":"19","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user W, Perrot S, Clauw DJ et al (2018) Unravelling fibromyalgia\u2014steps toward individualized management. J Pain 19(2):125\u2013134","journal-title":"J Pain"},{"issue":"1","key":"5818_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpain.2010.09.002","volume":"15","author":"G Affaitati","year":"2011","unstructured":"Affaitati G, Costantini R, Fabrizio A et al (2011) Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 15(1):61\u201369","journal-title":"Eur J Pain"},{"issue":"1","key":"5818_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.20452\/pamw.3877","volume":"127","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Ablin J, Perrot S et al (2017) Management of fibromyalgia: practical guides from recent evidence-based guidelines. Pol Arch Intern Med 127(1):47\u201356","journal-title":"Pol Arch Intern Med"},{"issue":"6","key":"5818_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1345\/aph.10254","volume":"35","author":"JD Smith","year":"2001","unstructured":"Smith JD, Terpening CM, Schmidt SO et al (2001) Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35(6):702\u2013706","journal-title":"Ann Pharmacother"},{"issue":"1\u20133","key":"5818_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2005.08.012","volume":"89","author":"S Dodd","year":"2005","unstructured":"Dodd S, Horgan D, Malhi GS et al (2005) To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 89(1\u20133):1\u201311","journal-title":"J Affect Disord"},{"issue":"8","key":"5818_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53(8):649\u2013659","journal-title":"Biol Psychiatry"},{"key":"5818_CR37","unstructured":"Souery D, Papakostas GI, Trivedi MH (2006) Treatment-resistant depression. J Clin Psychiatry 67(16)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05818-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05818-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05818-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T12:36:09Z","timestamp":1672576569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05818-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5818"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05818-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Disclosure form is attached in the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}